Verisian
4 known investors
Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.
BiotechDigital HealthHealthtechSaaS
Founders & leadership
Board
SG
Sunil GuptaStrategic Advisor
Investors · 4
Competitors · 3
by search overlapInstem4 shared keywordsInstem provides SaaS platforms for life sciences R&D, covering in silico data insights, preclinical study management, regulatory submission, and clinical trial analytics. Its software serves pharmaceutical companies, CROs, CDMOs, biotech, academic research, and agrichemical organizations for capturing, analyzing, and submitting regulatory data.
Saama4 shared keywordsSaama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.
Narrativa4 shared keywordsNarrativa provides agentic AI software that generates high-volume regulatory and commercial documentation—such as clinical study reports, patient narratives, and regulatory submissions—for pharmaceutical, biotech, and life sciences organizations. The platform is built for regulated environments to support clinical, regulatory, and commercialization workflows at scale.
Companies competing with Verisian for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Verisian do?
- Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.
- Who are Verisian's investors?
- Verisian's investors include Cambridge Angels group, Recode Ventures, Seedcamp, SuperSeed.